Initial dosing of intermittent vancomycin in adults: estimation of dosing interval in relation to dose and renal function.

CKD-EPI dosing nomogram glomerular filtration pharmacokinetics therapeutic drug monitoring vancomycin

Journal

European journal of hospital pharmacy : science and practice
ISSN: 2047-9956
Titre abrégé: Eur J Hosp Pharm
Pays: England
ID NLM: 101578294

Informations de publication

Date de publication:
09 2021
Historique:
received: 18 06 2019
revised: 24 07 2019
accepted: 30 07 2019
entrez: 24 8 2021
pubmed: 25 8 2021
medline: 2 4 2022
Statut: ppublish

Résumé

Due to the high interindividual variability in vancomycin pharmacokinetics, optimisation of its dosing is still challenging. This study aimed to explore vancomycin pharmacokinetics in adult patients and to propose an easy applicable dosing nomogram for initial treatment. Vancomycin pharmacokinetics was calculated in a two-compartmental model based on therapeutic drug monitoring data. A linear regression model was used to explore the relationship between vancomycin elimination half-life and glomerular filtration rate estimated according the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula. In the whole study population (n=66), vancomycin volume of distribution, clearance and half-life median (IQR) values were 0.69 (0.58-0.87) L/kg, 0.031 (0.022-0.050) L/h/kg and 14.4 (9.5-25.2) hours, respectively. Vancomycin half-life was associated with glomerular filtration rate (r We propose an easy-to-use dosing nomogram for vancomycin therapy initiation that allows individualisation of the dosing interval with respect to the administered dose size and functional renal status.

Identifiants

pubmed: 34426481
pii: ejhpharm-2019-002013
doi: 10.1136/ejhpharm-2019-002013
pmc: PMC8403779
doi:

Substances chimiques

Anti-Bacterial Agents 0
Vancomycin 6Q205EH1VU

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

276-279

Informations de copyright

© European Association of Hospital Pharmacists 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Can J Hosp Pharm. 2012 May;65(3):180-7
pubmed: 22783028
PLoS One. 2013 Oct 18;8(10):e77169
pubmed: 24204764
Clin Pharmacokinet. 2004;43(13):925-42
pubmed: 15509186
Eur J Hosp Pharm. 2019 Mar;26(2):85-88
pubmed: 31157105
Pharmacotherapy. 2009 Nov;29(11):1275-9
pubmed: 19873687
Ann Intern Med. 2009 May 5;150(9):604-12
pubmed: 19414839
Clin Infect Dis. 2006 Jan 1;42 Suppl 1:S5-12
pubmed: 16323120
Clin Pharmacokinet. 1986 Jul-Aug;11(4):257-82
pubmed: 3530582
Am J Ther. 2018 Sep/Oct;25(5):e602-e604
pubmed: 28650911
Infect Dis (Lond). 2017 Sep;49(9):674-679
pubmed: 28504034
Anaesth Intensive Care. 2014 Mar;42(2):178-84
pubmed: 24580382
J Infect Chemother. 2018 Apr;24(4):247-250
pubmed: 29195829
Intensive Care Med. 2013 Jul;39(7):1322-4
pubmed: 23604134

Auteurs

Martin Šíma (M)

Department of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic martin.sima@lf1.cuni.cz.

Jan Hartinger (J)

Department of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.

Tomáš Grus (T)

2nd Department of Surgery - Department of Cardiovascular Surgery, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.

Ondřej Slanař (O)

Department of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH